Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06363877 · ClinicalTrials.gov registry record · Phase 3
Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections
A Phase 3 study of Surgical Site Infection, sponsored by Loma Linda University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 1,100
- Enrollment target
- 1
- Study location
NCT06363877 is a Phase 3 study of Surgical Site Infection that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 1,100 participants, above the 524-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (110% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06363877, a Phase 3 study of Surgical Site Infection, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 1,100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multicenter randomized controlled trial of 1100 patients to evaluate the superiority of combined intraoperative wound irrigation with intraoperative peritoneal lavage with dilute aqueous povidone-iodine compared to normal saline in male and female patients between the ages of 18 and 80 years old undergoing emergency laparotomies with Centers for Disease Control (CDC) class 2 and 3 wounds.
Conditions Studied
Interventions
- DRUG Povidone-Iodine
- DRUG Normal Saline
Study Locations (1)
California
- Loma Linda University Health - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2026-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06363877
The ClinicalTrials.gov registry entry for NCT06363877 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 524-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (110% higher). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgical Site Infection appearing as the primary indexed condition, and to 2 interventions - of which Povidone-Iodine is the first listed.
NCT06363877 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06363877 about?
NCT06363877 is a clinical study titled "Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections". This is a multicenter randomized controlled trial of 1100 patients to evaluate the superiority of combined intraoperative wound irrigation with intraoperative peritoneal lavage with dilute aqueous povidone-iodine compared to normal saline in male and female patients between the ages of 18 and 80 yea...
What is the current status of trial NCT06363877?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 1,100 participants. The study started on 2024-06-03. Estimated completion is 2026-11.
What conditions does trial NCT06363877 study?
This clinical trial studies the following conditions: Surgical Site Infection.
What interventions are being tested in trial NCT06363877?
The interventions under investigation include: Povidone-Iodine (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT06363877?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06363877 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Site Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tobramycin Injection to Prevent Infection in Open Fractures
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
COMPLETED · Phase 3
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
RECRUITING · Phase 4
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
-
A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.